Alder Biopharma (ALDR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 0 | 0 | 0 | 6,436 | 38,784 |
| Gross Profit | N/A | N/A | N/A | 6,436 | 38,784 |
| Operating Expenses | 27,170 | 18,018 | 14,712 | 13,403 | 10,205 |
| Operating Income | -27,170 | -18,018 | -14,712 | -6,967 | 28,579 |
| Other Income | 173 | 363 | 59 | 25 | 67 |
| Pre-tax Income | -26,997 | -17,655 | -14,653 | -6,942 | 28,646 |
| Net Income Continuous | -26,997 | -17,655 | -14,653 | -6,942 | 28,646 |
| Net Income | $-26,997 | $-17,655 | $-14,653 | $-6,942 | $28,646 |
| EPS Basic Total Ops | -0.62 | -0.46 | -0.40 | 5.28 | 0.93 |
| EPS Basic Continuous Ops | -0.62 | -0.46 | -0.40 | 5.29 | 0.93 |
| EPS Diluted Total Ops | -0.62 | -0.46 | -0.40 | 5.20 | 0.88 |
| EPS Diluted Continuous Ops | -0.62 | -0.46 | -0.40 | 5.20 | 0.88 |
| EBITDA(a) | $-26,984 | $-17,828 | $-14,517 | $-6,793 | $28,751 |